Efficacy of high-dose therapy and autologous hematopoietic stem cell transplantation for non-Hodgkin's lymphoma in adults 60 years of age and older

Author:

Gopal AK,Gooley TA,Golden JB,Maloney DG,Bensinger WI,Petersdorf SH,Appelbaum FR,Press OW

Publisher

Springer Science and Business Media LLC

Subject

Transplantation,Hematology

Reference30 articles.

1. O'Reilly SE, Connors JM, Macpherson N et al. Lymphomas in the elderly Clin Geriatr Med 1997 13: 251–263

2. Devesa SS, Fears T . Non-Hodgkin's lymphoma time trends: United States and international data Cancer Res 1992 52: 5432s–5440s

3. Cohen H . Cancer and aging ASCO Educational Book American Society of Clinical Oncology: Alexandria, VA 1998 pp 223–226

4. Vital and Health Statistics: Trends in the Health of Older Americans, 1994: Centers for Disease Control and Prevention/National Center for Health Statistics, 1994. US Department of Health and Human Services, April 1995. Report No: Series 3, No. 30

5. Tirelli U, Errante D, Van Glabbeke M et al. CHOP is the standard regimen in patients > or = 70 years of age with intermediate-grade and high-grade non-Hodgkin's lymphoma: results of a randomized study of the European Organization for Research and Treatment of Cancer Lymphoma Cooperative Study Group J Clin Oncol 1998 16: 27–34

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3